Strategikon Pharma launches a new clinical trial platform Clinical Maestro

| By | Clinical Trials
853

Strategikon Pharma, a biotechnology startup, announced the release of the Clinical Maestro platform. Clinical Maestro is a new offering that significantly increases the accuracy and efficiency of clinical trial planning, budgeting and outsourcing.

Clinical Maestro is a cloud-based solution to more efficiently plan, source and manage complex clinical programs. Platform capabilities include modelling of operational and cost scenarios, forecasting, selecting and managing clinical service providers and clinical contracts.

Increased complexity and pressure for speed necessitates that clinical study teams base forward-looking decisions on data, rather than instinct. Better data requires faster analyses with greater precision. Managing complex outsourced relationships requires expanded collaboration across internal functions, trial phases and programs, and integrating key workflows with clinical service providers.

Clinical Maestro transforms processes for long-range planning, budgeting, procurement, contracting and vendor management with an end-to-end platform specifically created to support these functions. The result is unprecedented speed, precision and visibility that increases the efficiency and lowers the cost of running clinical trials.